Feed/Companies/Osanni Bio

Osanni Bio

As of 14 Oct 2026, Osanni Bio has raised $190M across 1 verified round on record; latest: $190 million Series B led by Patient Square Capital, announced 23 Jun 2026.

BUILT ON

Visit site

Osanni Bio, a development-stage therapeutics platform, is reinventing discovery and development of new medicines.

osanni.bioSan Francisco, California

LATEST ROUND

Series B

$190M · 2026-06-23

RAISED ON RECORD · USD

$190M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 1 publisher

Rounds

[ 1 ]

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Round	Amount	Announced	Lead	Buzz
Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$190M	2026-06-23	Patient Square Capital	No recent discussion
1 source [ VERIFIED ] read against 1 source [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: businesswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage

Osanni Bio

Rounds

Company

Rounds

Sources

Profile

Investors

Osanni Bio

Rounds

Profile

Sources

Series B$190M2026-06-231 source

Investors

Series B$190M2026-06-234 investors